美股市场个股详情
DXCM 德康医疗
- 128.370
- +1.720+1.36%
收盘价 05/03 16:00 (美东)
- 128.600
- +0.230+0.18%
盘后 19:46 (美东)
510.51亿总市值83.36市盈率TTM
129.220最高价126.910最低价177.90万股成交量127.220今开126.650昨收2.28亿成交额0.45%换手率98.75市盈率(静)3.98亿总股本142.00052周最高22.72市净率503.06亿流通值74.75052周最低--股息TTM3.92亿流通股164.863历史最高--股息率TTM1.82%振幅0.340历史最低128.424平均价1股每手
关于德康医疗公司
德康医疗公司为糖尿病患者设计并商业化连续血糖监测（CGM）系统。连续血糖监测系统可作为传统血糖仪工艺的替代方案，该公司正在发展其连续血糖监测系统，以提供与胰岛素泵的集成，以实现胰岛素的自动输送。
公司介绍
公司代码DXCM
公司名称德康医疗
上市日期2005/04/14
发行价格12.00
成立日期1999
所属市场纳斯达克
员工数量9600
证券类型海外普通股
年结日12-31
公司地址6340 Sequence Drive
城市San Diego
省份加利福尼亚州
国家美国
邮编92121
电话1-858-200-0200
董事高管
- 姓名
- 职务
- 年薪
- Kevin R. Sayer, C.P.A.
- President, Chief Executive Officer and Chairman of the Board
- 1571.22万
- Jake Leach
- Executive Vice President and Chief Operating Officer
- 493.80万
- Teri L Lawver
- Executive Vice President and Chief Commercial Officer
- 652.66万
- Sadie Stern
- Executive Vice President and Chief Human Resources Officer
- --
- Jereme M. Sylvain
- Executive Vice President, Chief Financial Officer and Principal Accounting Officer
- 425.49万
- Michael Brown
- Executive Vice President and Chief Legal Officer
- 434.28万
- Matthew Vincent Dolan
- Executive Vice President, Strategy, Corporate Development and Dexcom Labs
- --
- Rimma Driscoll
- Independent Director
- 40.47万
- Mark G. Foletta
- Lead Independent Director
- 39.35万
- Karen M. Dahut
- Independent Director
- 34.59万
- Bridgette P. Heller
- Independent Director
- 34.65万
- Steven R. Altman
- Independent Director
- 34.34万
- Richard A. Collins
- Independent Director
- 34.59万
- Nicholas Augustinos
- Independent Director
- 36.22万
- Kyle Malady
- Independent Director
- 34.34万
- Professor Dr. Eric J. Topol, M.D.
- Independent Director
- 34.65万
- Dr. Barbara E. Kahn
- Independent Director
- 34.84万
分析
目标价预测
暂无数据
热议
美股
综合热度
股票代码
最新价
涨跌幅
